AHP Protonix OTC Switch Considered As Long-Term Possibility
This article was originally published in The Tan Sheet
American Home Products is interested in the Rx-to-OTC switch possibilities of its proton pump inhibitor Protonix but is unlikely to pursue nonprescription status for the drug in the near-term.
You may also be interested in...
Johnson & Johnson's Viactiv acquisition adds a popular calcium supplement to its nascent McNeil Nutritionals division of niche products.
Company introduces 23rd product in FemFocus line with Daily Gold Pack for Women, a seven-pill, individually packaged regimen rolled out at NNFA trade show. Available in box of 30 daily packets, new offering comes with suggested retail price of $49.90 and includes Solgar's VM-75 Daily Multiple, Black Cohosh Root Extract, Omega-3 "700" and Vitamin E 200 IU. Entire FemFocus line also will begin implementing packaging changes, with structure/function claims soon to begin appearing in a band on the PDP, Solgar noted. Firm stated all new items targeting women will be part of FemFocus line
Chronic use of OTC Prilosec (omeprazole) may benefit patients with gastroesophageal reflux disease provided labeling explicitly lists appropriate warnings, advisory committee members concluded at a switch review for the heartburn drug.